Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species

Journal of Immunology

Volumn 178, Issue 12, 2007, Pages 8002-8012

  Barry, Ashley P ^a   Silvestri, Guido ^a,b,c   Safrit, Jeffrey T ^a   Sumpter, Beth ^a   Kozyr, Natalia ^a   McClure, Harold M ^b   Staprans, Silvija I ^a,d   Feinberg, Mark B ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CD8ALPHA ANTIGEN; MONOCLONAL ANTIBODY; OKT 8F; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CERCOCEBUS; CONTROLLED STUDY; HOST; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIREMIA; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 34250184098     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.12.8002     Document Type: Article

References (63)

1. Staprans, S. I., and M. B. Feinberg. 2004. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines. Exp. Rev. Vaccines 3(Suppl. 4): S5-S32.
2. Hahn, B. H., G. M. Shaw, K. M. De Cock, and P. M. Sharp. 2000. AIDS as a zoonosis: scientific and public health implications. Science 287: 607-614.
3. Fultz, P. N., T. P. Gordon, D. C. Anderson, and H. M. McClure. 1990. Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS 4: 619-625.
4. Rey-Cuille, M. A., J. L. Berthier, M. C. Bomsel-Demontoy, Y. Chaduc, L. Montagnier, A. G. Hovanessian, and L. A. Chakrabarti. 1998. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72: 3872-3886.
5. Chakrabarti, L. A., S. R. Lewin, L. Zhang, A. Gettie, A. Luckay, L. N. Martin, E. Skulsky, D. D. Ho, C. Cheng-Mayer, and P. A. Marx. 2000. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74: 1209-1223.
6. Silvestri, G., D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans, and M. B. Feinberg. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441-452.
7. Silvestri, G., A. Fedanov, S. Germon, N. Kozyr, W. J. Kaiser, D. A. Garber, H. McClure, M. B. Feinberg, and S. I. Staprans. 2005. Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79: 4043-4054.
8. Giorgi, J. V., R. H. Lyles, J. L. Matud, T. E. Yamashita, J. W. Mellors, L. E. Hultin, B. D. Jamieson, J. B. Margolick, C. R. Rinaldo, Jr., J. P. Phair, et al. 2002. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. Acquired Immune Defic. Syndr. 29: 346-355.
9. + T-cell changes independent of viral load. Blood 104: 942-947.
10. Hazenberg, M. D., S. A. Otto, B. H. van Benthem, M. T. Roos, R. A. Coutinho, J. M. Lange, D. Hamann, M. Prins, and F. Miedema. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
11. +, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable. Clin. Exp. Immunol. 122: 72-78.
12. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 16: 83-92.
13. + T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 18: 332-340.
14. + T cell dynamics during primary simian immunodeficiency virus infection in macaques: relationship of effector cell differentiation with the extent of viral replication. J. Immunol. 174: 6898-6908.
15. Dunham, R., P. Pagliardini, S. Gordon, B. Sumpter, J. Engram, A. Moanna, M. Paiardini, J. N. Mandl, B. Lawson, S. Garg, et al. 2006. The AIDS-resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108: 209-217.
16. + T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys. J. Virol. 80: 2771-2783.
17. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
18. + T-cell depletion in HIV disease. Nature 410: 974-979.
19. Koup, R. A., and D. D. Ho. 1994. Shutting down HIV. Nature 370: 416.
20. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279: 2103-2106.
21. + lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J. Virol. 75: 10187-10199.
22. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-I)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77: 2081-2092.
23. + T cells. Immunol. Lett. 79: 141-150.
24. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189: 991-998.
25. + lymphocytes. Science 283: 857-860.
26. Matano, T., R. Shibata, C. Siemon, M. Connors, H. C. Lane, and M. A. Martin. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72: 164-169.
27. + T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Exp. Med. 191: 1921-1931.
28. Demma, L. J., J. M. Logsdon, Jr., T. H. Vanderford, M. B. Feinberg, and S. I. Staprans. 2005. SIVsm quasispecies adaptation to a new simian host. PLoS Pathog. 1: E3.
29. Kaur, A., N. Kassis, C. L. Hale, M. Simon, M. Elliott, A. Gomez-Yafal, J. D. Lifson, R. C. Desrosiers, F. Wang, P. Barry, et al. 2003. Direct relationship between suppressio of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J. Virol. 77: 5749-5758.
30. Nowak, M. A., A. L. Lloyd, G. M. Vasquez, T. A. Wiltrout, L. M. Wahl, N. Bischofberger, J. Williams, A. Kinter, A. S. Fauci, V. M. Hirsch, and J. D. Lifson. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71: 7518-7525.
31. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
32. Wei, X., S. K. Ghosh, K. Sajal, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
33. Katz, D., W. Shi, P. W. Krug, R. Henkel, H. M. McClure, and J. K. Hilliard. 2002. Antibody cross-reactivity of alpha herpesviruses as mirrored in naturally infected primates. Arch. Virol. 147: 929-941.
34. Damania, B., and R. C. Desrosiers. 2001. Simian homologues of human herpes-virus 8. Philos. Trans. R. Soc. London B 356: 535-543.
35. Scholl, S., L. O. Mugge, M. C. Issa, C. Kasper, K. Pachmann, K. Hoffken, and H. G. Sayer. 2005. Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT. Bone Marrow Transplant. 35: 183-190.
36. Dunn, H. S., D. J. Haney, S. A. Ghanekar, P. Stepick-Biek, D. B. Lewis, and H. T. Maecker. 2002. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J. Infect. Dis. 186: 15-22.
37. Polic, B., H. Hengel, A. Krmpotic, J. Trgovcich, I. Pavic, P. Lucin, S. Jonjic, and U. H. Koszinowski. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188: 1047-1054.
38. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1996. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038-1044.
39. Gustafsson, A., V. Levitsky, J. Z. Zou, T. Frisan, T. Dalianis, P. Ljungman, O. Ringden, J. Winiarski, I. Ernberg, and M. G. Masucci. 2000. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 95: 807-814.
40. Comoli, P., M. Labirio, S. Basso, F. Baldanti, P. Grossi, M. Furione, M. Vigano, R. Fiocchi, G. Rossi, F. Ginevri, et al. 2002. Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood 99: 2592-2598.
41. + T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 101: 4290-4297.
42. + T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation. J. Infect. Dis. 190: 1596-1599.
43. + lymphocytes using a mouse-human chimeric monoclonal antibody. Am. J. Pathol. 154: 1923-1932.
44. Pitcher, C. J., S. I. Hagen, J. M. Walker, R. Lum, B. L. Mitchell, V. C. Maino, M. K. Axthelm, and L. J. Picker. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168: 29-43.
45. Mohri, H., A. S. Perelson, K. Tung, R. M. Ribeiro, B. Ramratnam, M. Markowitz, R. Kost, A. Hurley, L. Weinberger, D. Cesar, et al. 2001. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194: 1277-1287.
46. + T cells. Nature 417: 95-98.
47. Douek, D. C., L. J. Picker, and R. A. Koup. 2003. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21: 265-304.
48. Kraemer-Hansen, H., D. Dhenne-Bruns, S. Schroder, T. Loning, R. Dittmer, and B. Kremer. 1991. Experiences with monoclonal antibody orthoclone OKT3 following liver transplantation. Z. Gastroenterol. 29: 422-425.
49. Fujikawa, T., K. Numazaki, H. Asanuma, R. Kudo, and H. Tsutsumi. 2003. Frequency of human cytomegalovirus-specific T cells during pregnancy determined by intracellular cytokine staining. J. Med. Virol. 71: 527-531.
50. + T-lymphocytes in the course of active pulmonary tuberculosis. Eur. Respir. J. 24: 638-643.
51. Collins, K. R., M. E. Quiñones-Mateu, Z. Toossi, and E. J. Arts. 2002. Impact of tuberculosis on HIV-1 replication, diversity and disease progression. AIDS Rev. 4: 165-176.
52. Goletti, D., D. Weissman, R. W. Jackson, N. M. Graham, D. Vlahov, R. S. Klein, S. S. Munsiff, L. Ortona, R. Cauda, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157: 1271-1278.
53. Sulkowski, M. S., R. E. Chaisson, C. L. Karp, R. D. Moore, J. B. Margolick, and T. C. Quinn. 1998. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J. Infect. Dis. 178: 1642-1648.
54. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182: 1727-1737.
55. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N. Engl. J. Med. 334: 1222-1230.
56. Ostrowski, M. A., S. K. Stanley, J. S. Justement, K. Gantt, D. Goletti, and A. S. Fauci. 1997. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. AIDS Res. Hum. Retroviruses 13: 473-480.
57. Margolick, J. B., A. Munoz, A. D. Donnenberg, L. P. Park, N. Galai, J. V. Giorgi, M. R. O'Gorman, and J. Ferbas. 1995. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection: the multicenter AIDS cohort study. Nat. Med. 1: 674-680.
58. Grossman, Z., R. B. Herberman, N. Vatnik, and N. Intrator. 1998. Conservation of total T-cell counts during HIV infection: alternative hypotheses and implications. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17: 450-457.
59. Adleman, L. M., and D. Wofsy. 1996. Blind T-cell homeostasis in CD4-deficient mice. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11: 334-340.
60. Min, B., H. Yamane, J. Hu-Li, and W. E. Paul. 2005. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J. Immunol. 174: 6039-6044.
61. Kaur, A., J. Yang, D. Hempel, L. Gritz, G. P. Mazzara, H. McClure, and R. P. Johnson. 2000. Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with naturaf and experimentally acquired SIV infection. J. Immunol. 164: 934-943.
62. + T cells in control of SIV replication. J. Clin. Invest. 113: 836-845.
63. Regoes, R. R., R. Antia, D. A. Garber, G. Silvestri, M. B. Feinberg, and S. I. Staprans. 2004. Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection. J. Virol. 78: 4866-4875.